| Dr Ming Shuo He, MD | |
|
2021 N Macarthur Blvd, Suite 210, Irving, TX 75061-2219 | |
| (214) 379-2786 | |
| Not Available |
| Full Name | Dr Ming Shuo He |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 20 Years |
| Location | 2021 N Macarthur Blvd, Irving, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245478882 | NPI | - | NPPES |
| 438123YS68 | Other | TX | MEDICARE PTAN |
| 438123ZH18 | Other | TX | MEDICARE PTAN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkland Health & Hospital System | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
"Child mortality worldwide has fallen 41 percent since 1990, the result of myriad improvements in nutrition, access to vaccines and antibiotics, cleaner deliveries, better care of infants immediately after birth, and the use of insecticide-treated mosquito nets," according to "the findings of a report released Wednesday by three United Nations agencies and the World Bank," the Washington Post reports.
Vical Incorporated today announced the enrollment of the first subject in its Phase 1 trial of the company's Vaxfectin®-formulated plasmid DNA (pDNA) pandemic influenza vaccine. The trial will be conducted in collaboration with the U.S. Naval Medical Research Center (NMRC).
Although antibodies induced by SARS-CoV-2 infection are largely protective, they do not completely protect against reinfection in young people, as evidenced through a longitudinal, prospective study of more than 3,000 young, healthy members of the US Marines Corps conducted by researchers at the Icahn School of Medicine at Mount Sinai and the Naval Medical Research Center, published April 15 in The Lancet Respiratory Medicine.
Entrega, Inc., a new company developing oral drug delivery technologies, today announced its formation by Enlight Biosciences, a Boston-based company established in partnership with a group of leading global pharmaceutical companies.
› Verified 1 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
"Child mortality worldwide has fallen 41 percent since 1990, the result of myriad improvements in nutrition, access to vaccines and antibiotics, cleaner deliveries, better care of infants immediately after birth, and the use of insecticide-treated mosquito nets," according to "the findings of a report released Wednesday by three United Nations agencies and the World Bank," the Washington Post reports.
Vical Incorporated today announced the enrollment of the first subject in its Phase 1 trial of the company's Vaxfectin®-formulated plasmid DNA (pDNA) pandemic influenza vaccine. The trial will be conducted in collaboration with the U.S. Naval Medical Research Center (NMRC).
Although antibodies induced by SARS-CoV-2 infection are largely protective, they do not completely protect against reinfection in young people, as evidenced through a longitudinal, prospective study of more than 3,000 young, healthy members of the US Marines Corps conducted by researchers at the Icahn School of Medicine at Mount Sinai and the Naval Medical Research Center, published April 15 in The Lancet Respiratory Medicine.
Entrega, Inc., a new company developing oral drug delivery technologies, today announced its formation by Enlight Biosciences, a Boston-based company established in partnership with a group of leading global pharmaceutical companies.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ming Shuo He, MD 7415 Las Colinas Blvd, Suite 100, Irving, TX 75063-7568 Ph: (214) 379-2700 | Dr Ming Shuo He, MD 2021 N Macarthur Blvd, Suite 210, Irving, TX 75061-2219 Ph: (214) 379-2786 |
News Archive
"Child mortality worldwide has fallen 41 percent since 1990, the result of myriad improvements in nutrition, access to vaccines and antibiotics, cleaner deliveries, better care of infants immediately after birth, and the use of insecticide-treated mosquito nets," according to "the findings of a report released Wednesday by three United Nations agencies and the World Bank," the Washington Post reports.
Vical Incorporated today announced the enrollment of the first subject in its Phase 1 trial of the company's Vaxfectin®-formulated plasmid DNA (pDNA) pandemic influenza vaccine. The trial will be conducted in collaboration with the U.S. Naval Medical Research Center (NMRC).
Although antibodies induced by SARS-CoV-2 infection are largely protective, they do not completely protect against reinfection in young people, as evidenced through a longitudinal, prospective study of more than 3,000 young, healthy members of the US Marines Corps conducted by researchers at the Icahn School of Medicine at Mount Sinai and the Naval Medical Research Center, published April 15 in The Lancet Respiratory Medicine.
Entrega, Inc., a new company developing oral drug delivery technologies, today announced its formation by Enlight Biosciences, a Boston-based company established in partnership with a group of leading global pharmaceutical companies.
› Verified 1 days ago
Dr. Padmavathy Uppalapati, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1110 Cottonwood Ln, Suite 105, Irving, TX 75038 Phone: 972-607-2525 Fax: 972-252-8837 | |
Rupal Chiniwala, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 6750 N Macarthur Blvd, Suite 150, Irving, TX 75039 Phone: 972-373-0303 Fax: 972-373-8074 | |
Dr. Harikrishna Raja, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 440 W Lyndon B Johnson Fwy Ste 405, Irving, TX 75063 Phone: 972-993-5080 Fax: 972-993-5081 | |
Dr. Deepika Alavala Reddy, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1901 N Macarthur Blvd, Irving, TX 75061 Phone: 972-579-8100 Fax: 972-579-3972 | |
Mrs. Devyani V Deshpande, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7200 N State Hwy 161, Suite 220, Irving, TX 75039 Phone: 214-689-7806 Fax: 214-689-5970 | |
Dr. Sarju Waghela, D.O Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2001 N Macarthur Blvd, #630, Irving, TX 75061 Phone: 972-256-3537 Fax: 972-255-7916 | |
Nauman Siddiqi, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1110 Cottonwood Ln, # 105, Irving, TX 75038 Phone: 972-607-2525 |